CG
Caprock Group’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $776K | Buy |
+5,158
| New | +$776K | 0.02% | 549 |
|
|
2022
Q4 | – | Sell |
-1,120
| Closed | -$220K | – | 569 |
|
|
2022
Q3 | $220K | Sell |
1,120
-161
| -13% | -$31.6K | 0.02% | 494 |
|
|
2022
Q2 | $274K | Buy |
+1,281
| New | +$274K | 0.03% | 409 |
|
|
2021
Q4 | – | Sell |
-1,060
| Closed | -$437K | – | 589 |
|
|
2021
Q3 | $437K | Buy |
1,060
+152
| +17% | +$62.7K | 0.04% | 290 |
|
|
2021
Q2 | $336K | Buy |
908
+14
| +2% | +$5.18K | 0.03% | 334 |
|
|
2021
Q1 | $259K | Buy |
894
+42
| +5% | +$12.2K | 0.03% | 383 |
|
|
2020
Q4 | $213K | Buy |
+852
| New | +$213K | 0.02% | 426 |
|
|
2020
Q1 | – | Sell |
-1,442
| Closed | -$220K | – | 372 |
|
|
2019
Q4 | $220K | Sell |
1,442
-332
| -19% | -$50.7K | 0.04% | 311 |
|
|
2019
Q3 | $235K | Hold |
1,774
| – | – | 0.05% | 284 |
|
|
2019
Q2 | $252K | Hold |
1,774
| – | – | 0.05% | 261 |
|
|
2019
Q1 | $258K | Sell |
1,774
-45
| -2% | -$6.55K | 0.05% | 287 |
|
|
2018
Q4 | $206K | Hold |
1,819
| – | – | 0.05% | 313 |
|
|
2018
Q3 | $245K | Hold |
1,819
| – | – | 0.05% | 315 |
|
|
2018
Q2 | $204K | Sell |
1,819
-160
| -8% | -$17.9K | 0.04% | 392 |
|
|
2018
Q1 | $211K | Hold |
1,979
| – | – | 0.05% | 382 |
|
|
2017
Q4 | $208K | Sell |
1,979
-1,470
| -43% | -$155K | 0.04% | 417 |
|
|
2017
Q3 | $373K | Buy |
+3,449
| New | +$373K | 0.08% | 236 |
|